Effects of treatment with levamisole and glucans on mortality rates in Atlantic salmon (Salmo salar L.) suffering from amoebic gill disease
When levamisole was added to freshwater baths, used to treat Atlantic salmon for amoebic gill disease (AGD), there was a significant decrease in subsequent mortality of the fish. This was particularly the case in fish experiencing their first exposure to AGD. There were no significant differences in...
Gespeichert in:
| Veröffentlicht in: | Bulletin of the European Association of Fish Pathologists 2000-01, Vol.20 (1), p.23-27 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 27 |
|---|---|
| container_issue | 1 |
| container_start_page | 23 |
| container_title | Bulletin of the European Association of Fish Pathologists |
| container_volume | 20 |
| creator | Zilberg, D Findlay, V L Girling, P Munday, B L |
| description | When levamisole was added to freshwater baths, used to treat Atlantic salmon for amoebic gill disease (AGD), there was a significant decrease in subsequent mortality of the fish. This was particularly the case in fish experiencing their first exposure to AGD. There were no significant differences in responses to 1.25, 2.5 and 5.0 mg/L levamisole. It is proposed that this response is related to enhancement of the non-specific immune system. Oral supplementation with levamisole or glucans did not prevent subsequent moralities when Atlantic salmon, naive to AGD were subsequently exposed to this disease. |
| format | Article |
| fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_17644520</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17644520</sourcerecordid><originalsourceid>FETCH-LOGICAL-p184t-98860aa16e5f9a745459bf4d93655cd9af23133bbeedf4e4f64c7914f3e453003</originalsourceid><addsrcrecordid>eNotj8tOwzAQRbMAiar0H2aFYBGUxI_Ey6oqD6kSC2BdTZJxMXLsYjsgvoGfxhXM5mqko3t1zopFVVddWTVdd1GsYnyv8rGmVVIuip-t1jSkCF5DCoRpIpfgy6Q3sPSJk4neEqAb4WDnAV0GHUw-JLQmfUPARBGMg3Wy6JIZIKKdMnL9fMrThwF2tzcQ5zwUjDuADn4CnDz1GT8Ya2E0kTDSZXGu0UZa_eeyeL3bvmweyt3T_eNmvSuPdcdTqbpOVoi1JKEVtlxwoXrNR8WkEMOoUDesZqzviUbNiWvJh1bVXDPigmX1ZXH113sM_mOmmPZZcyCbDcjPcV-3knPRVOwX5Vlh1Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17644520</pqid></control><display><type>article</type><title>Effects of treatment with levamisole and glucans on mortality rates in Atlantic salmon (Salmo salar L.) suffering from amoebic gill disease</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Free E- Journals</source><creator>Zilberg, D ; Findlay, V L ; Girling, P ; Munday, B L</creator><creatorcontrib>Zilberg, D ; Findlay, V L ; Girling, P ; Munday, B L</creatorcontrib><description>When levamisole was added to freshwater baths, used to treat Atlantic salmon for amoebic gill disease (AGD), there was a significant decrease in subsequent mortality of the fish. This was particularly the case in fish experiencing their first exposure to AGD. There were no significant differences in responses to 1.25, 2.5 and 5.0 mg/L levamisole. It is proposed that this response is related to enhancement of the non-specific immune system. Oral supplementation with levamisole or glucans did not prevent subsequent moralities when Atlantic salmon, naive to AGD were subsequently exposed to this disease.</description><identifier>ISSN: 0108-0288</identifier><language>eng</language><subject>Freshwater ; Marine ; Salmo salar</subject><ispartof>Bulletin of the European Association of Fish Pathologists, 2000-01, Vol.20 (1), p.23-27</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781</link.rule.ids></links><search><creatorcontrib>Zilberg, D</creatorcontrib><creatorcontrib>Findlay, V L</creatorcontrib><creatorcontrib>Girling, P</creatorcontrib><creatorcontrib>Munday, B L</creatorcontrib><title>Effects of treatment with levamisole and glucans on mortality rates in Atlantic salmon (Salmo salar L.) suffering from amoebic gill disease</title><title>Bulletin of the European Association of Fish Pathologists</title><description>When levamisole was added to freshwater baths, used to treat Atlantic salmon for amoebic gill disease (AGD), there was a significant decrease in subsequent mortality of the fish. This was particularly the case in fish experiencing their first exposure to AGD. There were no significant differences in responses to 1.25, 2.5 and 5.0 mg/L levamisole. It is proposed that this response is related to enhancement of the non-specific immune system. Oral supplementation with levamisole or glucans did not prevent subsequent moralities when Atlantic salmon, naive to AGD were subsequently exposed to this disease.</description><subject>Freshwater</subject><subject>Marine</subject><subject>Salmo salar</subject><issn>0108-0288</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNotj8tOwzAQRbMAiar0H2aFYBGUxI_Ey6oqD6kSC2BdTZJxMXLsYjsgvoGfxhXM5mqko3t1zopFVVddWTVdd1GsYnyv8rGmVVIuip-t1jSkCF5DCoRpIpfgy6Q3sPSJk4neEqAb4WDnAV0GHUw-JLQmfUPARBGMg3Wy6JIZIKKdMnL9fMrThwF2tzcQ5zwUjDuADn4CnDz1GT8Ya2E0kTDSZXGu0UZa_eeyeL3bvmweyt3T_eNmvSuPdcdTqbpOVoi1JKEVtlxwoXrNR8WkEMOoUDesZqzviUbNiWvJh1bVXDPigmX1ZXH113sM_mOmmPZZcyCbDcjPcV-3knPRVOwX5Vlh1Q</recordid><startdate>20000101</startdate><enddate>20000101</enddate><creator>Zilberg, D</creator><creator>Findlay, V L</creator><creator>Girling, P</creator><creator>Munday, B L</creator><scope>7TN</scope><scope>F1W</scope><scope>H95</scope><scope>H98</scope><scope>L.G</scope></search><sort><creationdate>20000101</creationdate><title>Effects of treatment with levamisole and glucans on mortality rates in Atlantic salmon (Salmo salar L.) suffering from amoebic gill disease</title><author>Zilberg, D ; Findlay, V L ; Girling, P ; Munday, B L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p184t-98860aa16e5f9a745459bf4d93655cd9af23133bbeedf4e4f64c7914f3e453003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Freshwater</topic><topic>Marine</topic><topic>Salmo salar</topic><toplevel>online_resources</toplevel><creatorcontrib>Zilberg, D</creatorcontrib><creatorcontrib>Findlay, V L</creatorcontrib><creatorcontrib>Girling, P</creatorcontrib><creatorcontrib>Munday, B L</creatorcontrib><collection>Oceanic Abstracts</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) Aquaculture Abstracts</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) Professional</collection><jtitle>Bulletin of the European Association of Fish Pathologists</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zilberg, D</au><au>Findlay, V L</au><au>Girling, P</au><au>Munday, B L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of treatment with levamisole and glucans on mortality rates in Atlantic salmon (Salmo salar L.) suffering from amoebic gill disease</atitle><jtitle>Bulletin of the European Association of Fish Pathologists</jtitle><date>2000-01-01</date><risdate>2000</risdate><volume>20</volume><issue>1</issue><spage>23</spage><epage>27</epage><pages>23-27</pages><issn>0108-0288</issn><abstract>When levamisole was added to freshwater baths, used to treat Atlantic salmon for amoebic gill disease (AGD), there was a significant decrease in subsequent mortality of the fish. This was particularly the case in fish experiencing their first exposure to AGD. There were no significant differences in responses to 1.25, 2.5 and 5.0 mg/L levamisole. It is proposed that this response is related to enhancement of the non-specific immune system. Oral supplementation with levamisole or glucans did not prevent subsequent moralities when Atlantic salmon, naive to AGD were subsequently exposed to this disease.</abstract><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0108-0288 |
| ispartof | Bulletin of the European Association of Fish Pathologists, 2000-01, Vol.20 (1), p.23-27 |
| issn | 0108-0288 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_17644520 |
| source | EZB-FREE-00999 freely available EZB journals; Free E- Journals |
| subjects | Freshwater Marine Salmo salar |
| title | Effects of treatment with levamisole and glucans on mortality rates in Atlantic salmon (Salmo salar L.) suffering from amoebic gill disease |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T01%3A16%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20treatment%20with%20levamisole%20and%20glucans%20on%20mortality%20rates%20in%20Atlantic%20salmon%20(Salmo%20salar%20L.)%20suffering%20from%20amoebic%20gill%20disease&rft.jtitle=Bulletin%20of%20the%20European%20Association%20of%20Fish%20Pathologists&rft.au=Zilberg,%20D&rft.date=2000-01-01&rft.volume=20&rft.issue=1&rft.spage=23&rft.epage=27&rft.pages=23-27&rft.issn=0108-0288&rft_id=info:doi/&rft_dat=%3Cproquest%3E17644520%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17644520&rft_id=info:pmid/&rfr_iscdi=true |